Selective serotonin reuptake inhibitor use and the risk of hepatocellular carcinoma: a systematic review and dose–response analysis of cohort studies with one million participants
Akshaya Srikanth Bhagavathula, Benjamin Woolf, Jamal Rahmani, Kota Vidyasagar, Wubshet Tesfaye
Topics & Concepts
MedicineInternal medicineMeta-analysisRelative riskCohort studyObservational studySubgroup analysisPopulationHepatocellular carcinomaOncologyConfidence intervalSerotonin reuptake inhibitorProspective cohort studyAntidepressantEnvironmental healthHippocampusCancer, Stress, Anesthesia, and Immune ResponseCardiac Health and Mental HealthNeurotransmitter Receptor Influence on Behavior